業績紹介

ページタイトル画像

2015年

  • 2015年

2015年

  1. Kanaeda T, Ueda M, Arai M, Ishimura M, Kajiyama T, Hashiguchi N, Nakano M, Kondo Y, Hiranuma Y, Oyamada A, Yokosuka O, Kobayashi Y. Evaluation of periesophageal nerve injury after pulmonary vein isolation using the (13)C-acetate breath test. J Arrhythm. 2015 Dec;31(6):364-70. doi: 10.1016/j.joa.2015.06.004. PubMed PMID: 26702316; PubMed Central PMCID: PMC4672080.
  2. Haga Y, Kanda T, Sasaki R, Nakamura M, Nakamoto S, Yokosuka O. Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis. World J Gastroenterol. 2015 Dec 14;21(46):12989-95. doi: 10.3748/wjg.v21.i46.12989. Review. PubMed PMID: 26675364; PubMed Central PMCID: PMC4674717.
  3. Nakamura M, Kanda T, Sasaki R, Haga Y, Jiang X, Wu S, Nakamoto S, Yokosuka O. MicroRNA-122 Inhibits the Production of Inflammatory Cytokines by Targeting the PKR Activator PACT in Human Hepatic Stellate Cells. PLoS One. 2015 Dec 4;10(12):e0144295. doi: 10.1371/journal.pone.0144295. PubMed PMID: 26636761; PubMed Central PMCID: PMC4670168.
  4. Kanda T, Nakamoto S, Wu S, Nakamura M, Jiang X, Haga Y, Sasaki R, Yokosuka O. Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus. J Clin Transl Hepatol. 2015 Sep 28;3(3):205-10. doi: 10.14218/JCTH.2015.00016. Review. PubMed PMID: 26623267; PubMed Central PMCID: PMC4663202.
  5. Kanda T, Yasui S, Nakamura M, Arai M, Sasaki R, Haga Y, Wu S, Nakamoto S, Okamoto H, Yokosuka O. Recent Trend of Hepatitis E Virus Infection in Chiba Area, Japan: 3 of 5 Cases with Rheumatoid Arthritis. Case Rep Gastroenterol. 2015 Oct 17;9(3):317-26. doi: 10.1159/000441387. PubMed PMID: 26600768; PubMed Central PMCID: PMC4649734.
  6. Nakagawa T, Katsuno T, Noguchi Y, Mandai Y, Yoshihama S, Saito K, Maruoka D, Matsumura T, Arai M, Yokosuka O. Irsogladine Maleate Prevents Colitis in Interleukin-10 Gene-Deficient Mice by Reducing Interleukin-12 and -23 Production. Biol Pharm Bull. 2015;38(11):1681-8. doi: 10.1248/bpb.b15-00189. PubMed PMID: 26521820.
  7. Suzuki E, Chiba T, Ogasawara S, Saito T, Kanogawa N, Motoyama T, Ooka Y, Tawada A, Maruyama H, Ogawa M, Yokosuka O. Tolvaptan treatment for patients with decompensated cirrhosis and advanced hepatocellular carcinoma. Hepatol Res. 2015 Oct;45(10):E161-2. doi: 10.1111/hepr.12465. PubMed PMID: 26510648.
  8. Sakai Y, Tsuyuguchi T, Nishikawa T, Sugiyama H, Sasaki R, Sakamoto D, Watanabe Y, Nakamura M, Yasui S, Mikata R, Yokosuka O. New tapered metallic stent for unresectable malignant hilar bile duct obstruction. World J Clin Cases. 2015 Oct 16;3(10):887-93. doi: 10.12998/wjcc.v3.i10.887. PubMed PMID: 26488025; PubMed Central PMCID: PMC4607807.
  9. Maruoka D, Arai M, Ishigami H, Okimoto K, Matsumura T, Nakagawa T, Yokosuka O. Cold polypectomy for nonampullary duodenal adenoma. Endoscopy. 2015;47 Suppl 1 UCTN:E477-8. doi: 10.1055/s-0034-1392668. PubMed PMID: 26479293.
  10. Ogasawara S, Chiba T, Ooka Y, Suzuki E, Kanogawa N, Saito T, Motoyama T, Tawada A, Kanai F, Yokosuka O. Liver function assessment according to the Albumin-Bilirubin (ALBI) grade in sorafenib-treated patients with advanced hepatocellular carcinoma. Invest New Drugs. 2015 Dec;33(6):1257-62. doi: 10.1007/s10637-015-0292-9. PubMed PMID: 26462681.
  11. Nishida N, Ohashi J, Sugiyama M, Tsuchiura T, Yamamoto K, Hino K, Honda M, Kaneko S, Yatsuhashi H, Koike K, Yokosuka O, Tanaka E, Taketomi A, Kurosaki M, Izumi N, Sakamoto N, Eguchi Y, Sasazuki T, Tokunaga K, Mizokami M. Effects of HLA-DPB1 genotypes on chronic hepatitis B infection in Japanese individuals. Tissue Antigens. 2015 Dec;86(6):406-12. doi: 10.1111/tan.12684. PubMed PMID: 26449183.
  12. Fujiwara K, Yasui S, Yokosuka O. Corticosteroid and nucleoside analogue for hepatitis B virus-related acute liver failure. World J Gastroenterol. 2015 Sep 28;21(36):10485-6. doi: 10.3748/wjg.v21.i36.10485. PubMed PMID: 26420977; PubMed Central PMCID: PMC4579897.
  13. Kanda T, Sasaki R, Nakamoto S, Haga Y, Nakamura M, Shirasawa H, Okamoto H, Yokosuka O. The sirtuin inhibitor sirtinol inhibits hepatitis A virus (HAV) replication by inhibiting HAV internal ribosomal entry site activity. Biochem Biophys Res Commun. 2015 Oct 23;466(3):567-71. doi: 10.1016/j.bbrc.2015.09.083. PubMed PMID: 26388050.
  14. Kondo T, Maruyama H, Kiyono S, Sekimoto T, Shimada T, Takahashi M, Ogasawara S, Suzuki E, Ooka Y, Tawada A, Chiba T, Kanai F, Yokosuka O. Intensity-Based Assessment of Microbubble-Enhanced Ultrasonography: Phase-Related Diagnostic Ability for Cellular Differentiation of Hepatocellular Carcinoma. Ultrasound Med Biol. 2015 Dec;41(12):3079-87. doi: 10.1016/j.ultrasmedbio.2015.07.033. PubMed PMID: 26371403.
  15. Nakamoto S, Imazeki F, Arai M, Yasui S, Nakamura M, Haga Y, Sasaki R, Kanda T, Shirasawa H, Yokosuka O. Effect of Hepatitis C Virus Genotype 1b Core and NS5A Mutations on Response to Peginterferon Plus Ribavirin Combination Therapy. Int J Mol Sci. 2015 Sep 7;16(9):21177-90. doi: 10.3390/ijms160921177. PubMed PMID: 26370958; PubMed Central PMCID: PMC4613248.
  16. Sugiyama H, Tsuyuguchi T, Sakai Y, Mikata R, Yasui S, Watanabe Y, Sakamoto D, Nakamura M, Sasaki R, Senoo J, Kusakabe Y, Hayashi M, Yokosuka O. Current status of preoperative drainage for distal biliary obstruction. World J Hepatol. 2015 Aug 28;7(18):2171-6. doi: 10.4254/wjh.v7.i18.2171. Review. PubMed PMID: 26328029; PubMed Central PMCID: PMC4550872.
  17. Fujiwara K, Yasui S, Yokosuka O. Appropriate diagnostic criteria for fulminant autoimmune hepatitis. Eur J Gastroenterol Hepatol. 2015 Oct;27(10):1230-1. doi: 10.1097/MEG.0000000000000441. PubMed PMID: 26327503.
  18. Kanda T, Nakamoto S, Yokosuka O. Is the use of IL28B genotype justified in the era of interferon-free treatments for hepatitis C? World J Virol. 2015 Aug 12;4(3):178-84. doi: 10.5501/wjv.v4.i3.178. PubMed PMID: 26279979; PubMed Central PMCID: PMC4534809.
  19. Kanda T, Nakamura M, Sasaki R, Yasui S, Nakamoto S, Haga Y, Jiang X, Wu S, Tawada A, Arai M, Imazeki F, Yokosuka O. Sustained Virological Response after 8-Week Treatment of Simeprevir with Peginterferon α-2a plus Ribavirin in a Japanese Female with Hepatitis C Virus Genotype 1b and IL28B Minor Genotype. Case Rep Gastroenterol. 2015 Jul 8;9(2):215-20. doi: 10.1159/000437138. PubMed PMID: 26269697; PubMed Central PMCID: PMC4520186.
  20. Kondo T, Maruyama H, Sekimoto T, Shimada T, Takahashi M, Yokosuka O. Reversed portal flow: Clinical influence on the long-term outcomes in cirrhosis. World J Gastroenterol. 2015 Aug 7;21(29):8894-902. doi: 10.3748/wjg.v21.i29.8894. PubMed PMID: 26269679; PubMed Central PMCID: PMC4528032.
  21. Suzuki E, Chiba T, Ooka Y, Ogasawara S, Tawada A, Motoyama T, Kanogawa N, Saito T, Yoshikawa M, Yokosuka O. Transcatheter arterial infusion for advanced hepatocellular carcinoma: Who are candidates? World J Gastroenterol. 2015 Aug 7;21(29):8888-93. doi: 10.3748/wjg.v21.i29.8888. PubMed PMID: 26269678; PubMed Central PMCID: PMC4528031.
  22. Chiba T, Suzuki E, Saito T, Ogasawara S, Ooka Y, Tawada A, Iwama A, Yokosuka O. Biological features and biomarkers in hepatocellular carcinoma. World J Hepatol. 2015 Aug 8;7(16):2020-8. doi: 10.4254/wjh.v7.i16.2020. Review. PubMed PMID: 26261691; PubMed Central PMCID: PMC4528275.
  23. Kanda T, Ogasawara S, Chiba T, Haga Y, Omata M, Yokosuka O. Current management of patients with hepatocellular carcinoma. World J Hepatol. 2015 Jul 28;7(15):1913-20. doi: 10.4254/wjh.v7.i15.1913. PubMed PMID: 26244066; PubMed Central PMCID: PMC4517151.
  24. Sasaki R, Kanda T, Wu S, Nakamoto S, Haga Y, Jiang X, Nakamura M, Shirasawa H, Yokosuka O. Association between hepatitis B virus and MHC class I polypeptide-related chain A in human hepatocytes derived from human-mouse chimeric mouse liver. Biochem Biophys Res Commun. 2015 Sep 4;464(4):1192-5. doi: 10.1016/j.bbrc.2015.07.102. PubMed PMID: 26212443.
  25. Maruyama H, Kondo T, Sekimoto T, Kiyono S, Shimada T, Takahashi M, Okugawa H, Yokosuka O. Hyponatremia: a significant factor in a poor prognosis for cirrhosis with Child A/B after variceal eradication. J Hepatobiliary Pancreat Sci. 2015 Oct;22(10):771-8. doi: 10.1002/jhbp.282. PubMed PMID: 26202665.
  26. Jiang X, Kanda T, Wu S, Nakamoto S, Nakamura M, Sasaki R, Haga Y, Wakita T, Shirasawa H, Yokosuka O. Hepatitis C Virus Nonstructural Protein 5A Inhibits MG132-Induced Apoptosis of Hepatocytes in Line with NF-κB-Nuclear Translocation. PLoS One. 2015 Jul 2;10(7):e0131973. doi: 10.1371/journal.pone.0131973. Erratum in: PLoS One. 2015;10(7):e0134068. PubMed PMID: 26133378; PubMed Central PMCID: PMC4489642.
  27. Maruyama H, Kondo T, Sekimoto T, Yokosuka O. Differential Clinical Impact of Ascites in Cirrhosis and Idiopathic Portal Hypertension. Medicine (Baltimore). 2015 Jul;94(26):e1056. doi: 10.1097/MD.0000000000001056. PubMed PMID: 26131820; PubMed Central PMCID: PMC4504543.
  28. Saito T, Chiba T, Ogasawara S, Inoue M, Wakamatsu T, Motoyama T, Kanogawa N, Suzuki E, Ooka Y, Tawada A, Matsubara H, Yokosuka O. Fatal Diaphragmatic Hernia following Radiofrequency Ablation for Hepatocellular Carcinoma: A Case Report and Literature Review. Case Rep Oncol. 2015 May 28;8(2):238-45. doi: 10.1159/000431310. PubMed PMID: 26120308; PubMed Central PMCID: PMC4478306.
  29. Tawada A, Kanda T, Yokosuka O. Current and future directions for treating hepatitis B virus infection. World J Hepatol. 2015 Jun 18;7(11):1541-52. doi: 10.4254/wjh.v7.i11.1541. Review. PubMed PMID: 26085913; PubMed Central PMCID: PMC4462692.
  30. Nakamoto S, Kanda T, Shirasawa H, Yokosuka O. Antiviral therapies for chronic hepatitis C virus infection with cirrhosis. World J Hepatol. 2015 May 18;7(8):1133-41. doi: 10.4254/wjh.v7.i8.1133. Review. PubMed PMID: 26052402; PubMed Central PMCID: PMC4450190.
  31. Sasaki R, Kanda T, Nakamoto S, Haga Y, Nakamura M, Yasui S, Jiang X, Wu S, Arai M, Yokosuka O. Natural interferon-beta treatment for patients with chronic hepatitis C in Japan. World J Hepatol. 2015 May 18;7(8):1125-32. doi: 10.4254/wjh.v7.i8.1125. Review. PubMed PMID: 26052401; PubMed Central PMCID: PMC4450189.
  32. Minemura S, Tanaka T, Arai M, Okimoto K, Oyamada A, Saito K, Maruoka D, Matsumura T, Nakagawa T, Katsuno T, Kishimoto T, Yokosuka O. Gene expression profiling of laterally spreading tumors. BMC Gastroenterol. 2015 Jun 6;15:64. doi: 10.1186/s12876-015-0295-1. PubMed PMID: 26048755; PubMed Central PMCID: PMC4456718.
  33. Maruyama H, Kondo T, Kiyono S, Sekimoto T, Takahashi M, Okugawa H, Yokosuka O. Relationship and interaction between serum sodium concentration and portal hemodynamics in patients with cirrhosis. J Gastroenterol Hepatol. 2015 Nov;30(11):1635-42. doi: 10.1111/jgh.13006. PubMed PMID: 25968445.
  34. Kurosawa J, Tawada K, Mikata R, Ishihara T, Tsuyuguchi T, Saito M, Shimofusa R, Yoshitomi H, Ohtsuka M, Miyazaki M, Yokosuka O. Prognostic relevance of apparent diffusion coefficient obtained by diffusion-weighted MRI in pancreatic cancer. J Magn Reson Imaging. 2015 Dec;42(6):1532-7. doi: 10.1002/jmri.24939. PubMed PMID: 25946483.
  35. Omata M, Kanda T, Yokosuka O, Crawford D, Al-Mahtab M, Wei L, Ibrahim A, Lau GK, Sharma BC, Hamid SS, Chuang WL, Dokmeci AK. Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries. Hepatol Int. 2015 Oct;9(4):486-507. doi: 10.1007/s12072-015-9630-4. Review. PubMed PMID: 25941137.
  36. Ogasawara S, Chiba T, Ooka Y, Kanogawa N, Motoyama T, Suzuki E, Tawada A, Azemoto R, Shinozaki M, Yoshikawa M, Yokosuka O. A prognostic score for patients with intermediate-stage hepatocellular carcinoma treated with transarterial chemoembolization. PLoS One. 2015 Apr 28;10(4):e0125244. doi: 10.1371/journal.pone.0125244. PubMed PMID: 25919025; PubMed Central PMCID: PMC4412579.
  37. Sakai Y, Tsuyuguchi T, Sugiyama H, Sasaki R, Sakamoto D, Nakamura M, Watanabe Y, Nishikawa T, Yasui S, Mikata R, Yokosuka O. Endoscopic papillary large balloon dilation for bile duct stones in elderly patients. World J Clin Cases. 2015 Apr 16;3(4):353-9. doi: 10.12998/wjcc.v3.i4.353. PubMed PMID: 25879007; PubMed Central PMCID: PMC4391005.
  38. Mizokami M, Yokosuka O, Takehara T, Sakamoto N, Korenaga M, Mochizuki H, Nakane K, Enomoto H, Ikeda F, Yanase M, Toyoda H, Genda T, Umemura T, Yatsuhashi H, Ide T, Toda N, Nirei K, Ueno Y, Nishigaki Y, Betular J, Gao B, Ishizaki A, Omote M, Mo H, Garrison K, Pang PS, Knox SJ, Symonds WT, McHutchison JG, Izumi N, Omata M. Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial. Lancet Infect Dis. 2015 Jun;15(6):645-53. doi: 10.1016/S1473-3099(15)70099-X. PubMed PMID: 25863559.
  39. Ogasawara S, Chiba T, Ooka Y, Kanogawa N, Saito T, Motoyama T, Suzuki E, Tawada A, Kanai F, Yokosuka O. Sorafenib treatment in Child-Pugh A and B patients with advanced hepatocellular carcinoma: safety, efficacy and prognostic factors. Invest New Drugs. 2015 Jun;33(3):729-39. doi: 10.1007/s10637-015-0237-3. PubMed PMID: 25861764.
  40. Sekimoto T, Maruyama H, Kiyono S, Kondo T, Shimada T, Takahashi M, Yokosuka O, Yamaguchi T. Liver Stiffness: A Significant Relationship with the Waveform Pattern in the Hepatic Vein. Ultrasound Med Biol. 2015 Jul;41(7):1801-7. doi: 10.1016/j.ultrasmedbio.2015.03.002. PubMed PMID: 25858000.
  41. Hirotsu Y, Kanda T, Matsumura H, Moriyama M, Yokosuka O, Omata M. HCV NS5A resistance-associated variants in a group of real-world Japanese patients chronically infected with HCV genotype 1b. Hepatol Int. 2015 Jul;9(3):424-30. doi: 10.1007/s12072-015-9624-2. PubMed PMID: 25791176.
  42. Sato T, Kondo F, Ebara M, Sugiura N, Okabe S, Sunaga M, Yoshikawa M, Suzuki E, Ogasawara S, Shinozaki Y, Ooka Y, Chiba T, Kanai F, Kishimoto T, Nakatani Y, Fukusato T, Yokosuka O. Natural history of large regenerative nodules and dysplastic nodules in liver cirrhosis: 28-year follow-up study. Hepatol Int. 2015 Apr;9(2):330-6. doi: 10.1007/s12072-015-9620-6. PubMed PMID: 25788204; PubMed Central PMCID: PMC4387310.
  43. Kamezaki H, Azemoto R, Yokosuka O, Fujimoto T, Obu M, Saito M, Yoshida Y, Koma Y, Maruyama H, Fujimori M. Suspicion of superior mesenteric artery syndrome in a patient with severe gastric dilatation after catheter ablation. Intern Med. 2015;54(6):605-9. doi: 10.2169/internalmedicine.54.3276. PubMed PMID: 25786450.
  44. Kanda T, Yokosuka O, Omata M. Faldaprevir for the treatment of hepatitis C. Int J Mol Sci. 2015 Mar 4;16(3):4985-96. doi: 10.3390/ijms16034985. Review. PubMed PMID: 25749475; PubMed Central PMCID: PMC4394460.
  45. Jiang X, Kanda T, Nakamoto S, Saito K, Nakamura M, Wu S, Haga Y, Sasaki R, Sakamoto N, Shirasawa H, Okamoto H, Yokosuka O. The JAK2 inhibitor AZD1480 inhibits hepatitis A virus replication in Huh7 cells. Biochem Biophys Res Commun. 2015 Mar 20;458(4):908-12. doi: 10.1016/j.bbrc.2015.02.058. PubMed PMID: 25704089.
  46. Kanogawa N, Ogasawara S, Chiba T, Saito T, Motoyama T, Suzuki E, Ooka Y, Tawada A, Kanda T, Mikami S, Azemoto R, Kaiho T, Shinozaki M, Ohtsuka M, Miyazaki M, Yokosuka O. Sustained virologic response achieved after curative treatment of hepatitis C virus-related hepatocellular carcinoma as an independent prognostic factor. J Gastroenterol Hepatol. 2015 Jul;30(7):1197-204. doi: 10.1111/jgh.12925. PubMed PMID: 25682720.
  47. Okusaka T, Ueno H, Ikeda M, Mitsunaga S, Ozaka M, Ishii H, Yokosuka O, Ooka Y, Yoshimoto R, Yanagihara Y, Okita K. Phase 1 and pharmacological trial of OPB-31121, a signal transducer and activator of transcription-3 inhibitor, in patients with advanced hepatocellular carcinoma. Hepatol Res. 2015 Dec;45(13):1283-91. doi: 10.1111/hepr.12504. PubMed PMID: 25676869.
  48. Maruyama H, Kondo T, Kiyono S, Sekimoto T, Takahashi M, Yokosuka O. Influence of splenorenal shunt on long-term outcomes in cirrhosis. Scand J Gastroenterol. 2015 May;50(5):593-600. doi: 10.3109/00365521.2014.1003401. PubMed PMID: 25635924.
  49. Nishikawa T, Tsuyuguchi T, Ishigami H, Sakai Y, Sugiyama H, Nakatani Y, Ohtsuka M, Miyazaki M, Yokosuka O. Peroral cholangioscopy-guided forceps biopsy to evaluate a cicatricial stricture of the biliary duct (with video). Gastrointest Endosc. 2015 Apr;81(4):1030-1; discussion 1031. doi: 10.1016/j.gie.2014.10.008. PubMed PMID: 25597423.
  50. Matsumoto A, Yatsuhashi H, Nagaoka S, Suzuki Y, Hosaka T, Tsuge M, Chayama K, Kanda T, Yokosuka O, Nishiguchi S, Saito M, Miyase S, Kang JH, Shinkai N, Tanaka Y, Umemura T, Tanaka E. Factors associated with the effect of interferon-α sequential therapy in order to discontinue nucleoside/nucleotide analog treatment in patients with chronic hepatitis B. Hepatol Res. 2015 Dec;45(12):1195-202. doi: 10.1111/hepr.12488. PubMed PMID: 25594111.
  51. Maruoka D, Arai M, Ishigami H, Okimoto K, Saito K, Minemura S, Matsumura T, Nakagawa T, Katsuno T, Yokosuka O. Sporadic nonampullary duodenal adenoma/carcinoma is associated with not only colon adenoma/carcinoma but also gastric cancer: association of location of duodenal lesions with comorbid diseases. Scand J Gastroenterol. 2015 Mar;50(3):333-40. doi: 10.3109/00365521.2014.1003399. PubMed PMID: 25582657.
  52. Fujiwara K, Yasui S, Nakano M, Yonemitsu Y, Arai M, Kanda T, Fukuda Y, Oda S, Yokosuka O. Severe and fulminant hepatitis of indeterminate etiology in a Japanese center. Hepatol Res. 2015 Oct;45(10):E141-9. doi: 10.1111/hepr.12483. PubMed PMID: 25582192.
  53. Nakamura M, Kanda T, Nakamoto S, Haga Y, Sasaki R, Jiang X, Yasui S, Arai M, Yokosuka O. Reappearance of serum hepatitis B viral DNA in patients with hepatitis B surface antigen seroclearance. Hepatology. 2015 Oct;62(4):1329. doi: 10.1002/hep.27693. PubMed PMID: 25573053.
  54. Fujiwara K, Oda S, Abe R, Yokosuka O. On-line hemodiafiltration or high-flow continuous hemodiafiltration is one of the most effective artificial liver support devices for acute liver failure in Japan. J Hepatobiliary Pancreat Sci. 2015 Mar;22(3):246-7. doi: 10.1002/jhbp.204. Review. PubMed PMID: 25565563.
  55. Maruyama H, Kondo T, Sekimoto T, Takahashi M, Fujiwara K, Imazeki F, Yokosuka O. Retrograde detection of the intrahepatic portal vein in primary biliary cirrhosis: is sinusoidal blockage the underlying pathophysiology? Eur J Gastroenterol Hepatol. 2015 Mar;27(3):321-7. doi: 10.1097/MEG.0000000000000268. PubMed PMID: 25563140.
  56. Tawada A, Chiba T, Ooka Y, Kanogawa N, Saito T, Motoyama T, Ogasawara S, Suzuki E, Kanai F, Yoshikawa M, Yokosuka O. Transarterial chemoembolization with miriplatin plus epirubicin in patients with hepatocellular carcinoma. Anticancer Res. 2015 Jan;35(1):549-54. PubMed PMID: 25550601.
  57. Kanda T, Yokosuka O. The androgen receptor as an emerging target in hepatocellular carcinoma. J Hepatocell Carcinoma. 2015 Jun 26;2:91-9. doi: 10.2147/JHC.S48956. Review. PubMed PMID: 27508198; PubMed Central PMCID: PMC4918288.
  58. Sekimoto T, Maruyama H, Kondo T, Shimada T, Kiyono S, Yokosuka O. Potential stagnation in the splanchnic hemodynamics demonstrated by the dynamic microbubbles in chronic liver disease. J Gastroenterol Hepatol. 2015 Jun;30(6):1001-8. doi: 10.1111/jgh.12875. PubMed PMID: 25532613.
  59. Suzuki E, Ooka Y, Chiba T, Kobayashi K, Kanogawa N, Motoyama T, Saito T, Ogasawara S, Tawada A, Yokosuka O. Incidental tumor necrosis caused by the interventional alteration of hepatic arterial flow in patients with advanced hepatocellular carcinoma. Clin J Gastroenterol. 2015 Feb;8(1):41-6. doi: 10.1007/s12328-014-0542-y. PubMed PMID: 25481841; PubMed Central PMCID: PMC4331596.
  60. Ohyama H, Mikata R, Ishihara T, Tsuyuguchi T, Sakai Y, Sugiyama H, Yasui S, Ishii K, Itoh S, Nishikawa T, Watanabe Y, Yokosuka O. Efficacy of stone density on noncontrast computed tomography in predicting the outcome of extracorporeal shock wave lithotripsy for patients with pancreatic stones. Pancreas. 2015 Apr;44(3):422-8. doi: 10.1097/MPA.0000000000000277. PubMed PMID: 25438070.
  61. Kawaguchi T, Nagao Y, Abe K, Imazeki F, Honda K, Yamasaki K, Miyanishi K, Taniguchi E, Kakuma T, Kato J, Seike M, Yokosuka O, Ohira H, Sata M. Effects of branched-chain amino acids and zinc-enriched nutrients on prognosticators in HCV-infected patients: a multicenter randomized controlled trial. Mol Med Rep. 2015 Mar;11(3):2159-66. doi: 10.3892/mmr.2014.2943. PubMed PMID: 25394681.
  62. Shimada T, Maruyama H, Kondo T, Sekimoto T, Takahashi M, Yokosuka O. Impact of splenic circulation: non-invasive microbubble-based assessment of portal hemodynamics. Eur Radiol. 2015 Mar;25(3):812-20. doi: 10.1007/s00330-014-3476-3. PubMed PMID: 25361826.
  63. Fujiwara K, Yasui S, Yonemitsu Y, Arai M, Kanda T, Nakano M, Oda S, Yokosuka O. Fixed point observation of etiology of acute liver failure according to the novel Japanese diagnostic criteria. J Hepatobiliary Pancreat Sci. 2015 Mar;22(3):225-9. doi: 10.1002/jhbp.178. PubMed PMID: 25339364.
  64. Fujiwara K, Yasui S, Yonemitsu Y, Arai M, Kanda T, Nakano M, Oda S, Yokosuka O. Importance of the poor prognosis of severe and fulminant hepatitis in the elderly in an era of a highly aging society: Analysis in a Japanese center. Hepatol Res. 2015 Aug;45(8):863-71. doi: 10.1111/hepr.12426. PubMed PMID: 25238570.
  65. Maruoka D, Arai M, Tanaka T, Okimoto K, Oyamada A, Minemura S, Tsuboi M, Matsumura T, Nakagawa T, Kanda T, Katsuno T, Imazeki F, Yokosuka O. Mosapride citrate increases postprandial glucagon-like peptide-1, insulin, and gene expression of sweet taste receptors. Dig Dis Sci. 2015 Feb;60(2):345-53. doi: 10.1007/s10620-014-3271-7. PubMed PMID: 25008428.
  66. Chiba T, Saito T, Yuki K, Zen Y, Koide S, Kanogawa N, Motoyama T, Ogasawara S, Suzuki E, Ooka Y, Tawada A, Otsuka M, Miyazaki M, Iwama A, Yokosuka O. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma. Int J Cancer. 2015 Jan 15;136(2):289-98. doi: 10.1002/ijc.28985. PubMed PMID: 24844570.
  67. Yasui S, Fujiwara K, Nakamura M, Miyamura T, Yonemitsu Y, Mikata R, Arai M, Kanda T, Imazeki F, Oda S, Yokosuka O. Virological efficacy of combination therapy with corticosteroid and nucleoside analogue for severe acute exacerbation of chronic hepatitis B. J Viral Hepat. 2015 Feb;22(2):94-102. doi: 10.1111/jvh.12258. PubMed PMID: 24750410.